MDCG Position Paper | Notice to manufacturers and notified bodies to ensure timely compliance with MDR and IVDR requirements

January 3, 2024

The Medical Device Coordination Group (MDCG) of the European Commission issued a position paper urgently calling manufacturers to transition to the Regulations and submit their application for their medical devices certification without further delay.

With the adoption of Regulations (EU) 2017/745 (MDR) and 2017/746 (IVDR), the regulatory framework for medical devices and in vitro diagnostic medical devices (IVD) has significantly changed.

However, data provided by notified bodies shows limited progress in terms of applications submitted and certificates issued, being the situation even more worrisome for IVDs. While only around 8% of IVDs required notified body involvement for conformity assessment under Directive 98/79/EC on in vitro diagnostic medical devices (IVDD), this proportion is around 80% under the IVDR.

Manufacturers should keep in mind that the duration of the conformity assessment process once the application is submitted to a notified body currently takes longer than under the former directives. Notified body data reveals that a significant number of manufacturers’ applications are incomplete, potentially causing delays in the certification process. Given the established deadlines by the Regulations, manufacturers are strongly advised to intensify their efforts for an early transition and avoid further submission delays, as this could result in bottlenecks in notified body workflows and potential shortages of products in the market.

Need help? We can assist in getting your medical devices certified under MDR and IVDR. Contact us asap!

Send us an email: [email protected]

Or schedule a free 30-minute meeting here: SCHEDULE A FREE MEETING HERE

Search News & Events

  • Filter by category

Share

Related news and events

NEWS | FAQs on the European Health Data Space

The EHDS Regulation has three main parts, each with different addressees:

Chapter II on primary use provides additional rights to patients and establishes the technical infrastructure necessary for their implementation.

Chapter III on Electronic Health Record (EHR) systems is addressed to manufacturers and other economic operators who make EHR systems available on the market.

Chapter IV on secondary use is addressed to health data holders and users.

EVENT | DIA Europe

DIA Europe 2025 will focus on sustainability, innovation and collaboration – three key pillars for shaping the future of healthcare. From the environmental impact of pharmaceuticals and of the drug development lifecycle to sustainable partnerships and sustainable healthcare systems, DIA Europe 2025 will be the prime opportunity to discuss how collaboration and innovation can support sustainability in healthcare and each stakeholder’s role in making it happen.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting